Caris Life Sciences Publishes Study Showing Whole Exome Measurement of Tumor Mutational Burden Results in Increased Overall Survival Compared to Estimates from Targeted Gene Panels
Go back to Caris Life Sciences Publishes Study Showing Whole Exome Measurement of Tumor Mutational Burden Results in Increased Overall Survival Compared to Estimates from Targeted Gene Panels| CACI INTERNATIONAL CLA (NASDAQ: CAI) | Delayed: 17.31 -1.16 (6.28%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $18.47 | 52 Week High | $11.53 | |||
| Open | $18.61 | 52 Week Low | $4.83 | |||
| Day High | $18.79 | P/E | 5.87 | |||
| Day Low | $17.27 | EPS | $2.95 | |||
| Volume | 3,023,468 | |||||
